People aged ≥6 months with medical conditions associated with an increased risk of influenza disease and complications are recommended to receive influenza vaccine every year
People aged ≥6 months with medical conditions specified in this List. Specified medical conditions associated with increased risk of influenza disease and severe outcomes are recommended to receive annual influenza vaccine.
Influenza vaccine is funded through the NIP for people with certain medical conditions that increase their risk of severe influenza complications. For details see the National Immunisation Program Schedule.
People with these specific medical conditions have a higher risk of influenza or severe outcomes from influenza.9-29
People who have received a transplant
People who have received a transplant
People who have had a haematopoietic stem cell transplant or solid organ transplant and are receiving influenza vaccine for the first time after transplant are recommended to receive:
- 2 doses at least 4 weeks apart the 1st time they receive influenza vaccine after the transplant
- 1 dose each year after that
Vaccine doses for people with the risk conditions in this list are funded under the NIP unless otherwise noted.
| Conditions |
|---|
Immunocompromising conditions including:
|
Functional or anatomical asplenia, including:
|
Cardiac disease, including:
|
Chronic respiratory conditions, including:
|
Chronic neurological conditions, including:
|
Chronic metabolic disorders, including:
|
| Chronic renal failure |
| Long-term aspirin therapy in children aged 5 to 10 years |
| Chronic liver diseasea |
| Down syndromea |
| Obesity (body mass index ≥30 kg per m2) a |
| Harmful use of alcohola |
|
Footnotes: a: Not funded under the NIP |